Endometrial carcinoma associated with hyperplasia - Immunohistochemical study of angiogenesis and p53 expression

Gynecologic Oncology

Volumn 72, Issue 1, 1999, Pages 51-55

  Kaku, Tsunehisa ^a   Kamura, Toshiharu ^a   Hirakawa, Toshio ^a   Sakai, Kunihiro ^a   Amada, Satoshi ^a   Kobayashi, Hiroaki ^a   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Endometrial carcinoma; Endometrial hyperplasia; Microvessel density; P53

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ANGIOGENESIS; ARTICLE; CANCER STAGING; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERUS CARCINOMA;

EID: 0032956565     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5230     Document Type: Article

References (19)

1. Kurman RJ, Zaino RJ, Norris NJ: Endometrial Carcinoma, in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract. 4th ed. New York, Springer-Verlag, 1994, pp 439-486
2. Silverberg SG, Kurman RJ: Atlas of Tumor Pathology. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. 3rd series, fascicle 3. Washington, DC, Armed Forces Institute of Pathology, 1992
3. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17, 1983
4. Deligdisch L, Cohen CJ: Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 56:1452-1455, 1985
5. Beckner ME, Mori T, Silverberg SG: Endometrial carcinoma: nontumor factors in prognosis. Int J Gynecol Pathol 4:131-145, 1985
6. Deligdisch L, Holinka CF: Progesterone receptors in two groups of endometrial carcinoma. Cancer 57:1385-1388, 1986
7. Kaku T, Tsukamoto N, Hachisuga T, Tsuruchi N, Sakai K, Hirakawa T, Amada S, Saito T, Kamura T, Nakano H: Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 60:22-25, 1996
8. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147:9-19, 1995
9. Kaku T, Kamura T, Kinukawa N, Kobayashi H, Sakai K, Tsuruchi N, Saito T, Kawauchi S, Tsuneyoshi M, Nakano H: Angiogenesis in endometrial carcinoma. Cancer 80:741-747, 1997
10. Silverberg, SG: Hyperplasia and carcinoma of the endometrium. Semin Diagn Pathol 5:135-153, 1988
11. Bur ME, Periman C, Edelmann L, Fey E, Rose PG: p53 expression in neoplasms of the uterine corpus. Am J Clin Pathol 98:81-87, 1992
12. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC, Marks JR: Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52:1622-1627, 1992
13. Ambros RA, Vigna PA, Figge J, Kallakury BVS, Mastrangelo A, Eastman AY, Malfetano J, Figge HL, Ross JS: Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Cancer 73:1686-1692, 1994
14. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, Ueshima H: Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 58:14-19, 1994
15. Ambros RA, Sheehan CE, Kallakury BVS, Ross JS, Malfetano J, Paunovich E, Figge J: MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma. Mod Pathol 9:1165-1169, 1996
16. Sherman ME, Bur ME, Kurman RJ: p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268-1274, 1995
17. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333:1757-1763, 1995
18. Abulafia O, Triest WE, Sherer DM, Hansen CC, Ghezzi F: Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol 86:479-485, 1995
19. Kirschner CV, Alanis-Amezcua JM, Martin VG, Luna N, Morgan E, Yang JJ, Yordan EL: Angiogenesis factor in endometrial carcinoma: a new prognostic indicator? Am J Obstet Gynecol 174:1879-1884, 1996